Related Experiment Videos
The codon 72 polymorphic variants of p53 have markedly different apoptotic potential
Patrick Dumont1, J I-Ju Leu, Anthony C Della Pietra
1Department of Pharmacology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, Pennsylvania 19111, USA.
Nature Genetics
|February 5, 2003
Summary
The Arg72 variant of the TP53 gene (p53) induces apoptosis more effectively than the Pro72 variant. This difference is linked to enhanced mitochondrial localization and cytochrome c release, potentially impacting cancer risk and treatment.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- The TP53 gene encodes the p53 protein, a critical regulator of apoptosis.
- A common polymorphism at amino acid position 72 results in two p53 variants: Pro72 and Arg72.
- The proline-rich domain of p53 is essential for full apoptosis induction.
Purpose of the Study:
- To investigate the functional differences between the Pro72 and Arg72 variants of p53.
- To determine if these variants exhibit distinct apoptotic potentials.
- To explore the mechanisms underlying any observed functional differences.
Main Methods:
- Utilized cell lines with inducible TP53 alleles encoding Pro72 and Arg72 variants.
- Examined apoptosis induction in cells expressing endogenous p53.
- Assessed mitochondrial localization of p53 variants and cytochrome c release.
Main Results:
- The Arg72 p53 variant demonstrated significantly enhanced apoptosis induction compared to the Pro72 variant.
- Arg72 variant showed greater localization to mitochondria.
- Mitochondrial localization of Arg72 was associated with increased cytochrome c release into the cytosol.
Conclusions:
- The Pro72 and Arg72 polymorphic variants of p53 are functionally distinct.
- Enhanced mitochondrial targeting and subsequent cytochrome c release contribute to the higher apoptotic potential of the Arg72 variant.
- These functional differences may have implications for cancer risk and therapeutic strategies.